Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH3 MYH13 MYO9B	1.24e-04	38	51	3	GO:0000146
GeneOntologyMolecularFunction	actin binding	MYH3 DST MYH13 MYO9B SPTA1 SYNE2 ACTN2	2.03e-04	479	51	7	GO:0003779
GeneOntologyMolecularFunction	actin filament binding	MYH3 MYH13 MYO9B SPTA1 ACTN2	2.79e-04	227	51	5	GO:0051015
GeneOntologyCellularComponent	myofibril	MYH3 DST MYH13 SYNE2 ACTN2 GRIN2B	6.44e-05	273	53	6	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	MYH3 DST MYH13 SYNE2 ACTN2 GRIN2B	8.99e-05	290	53	6	GO:0043292
GeneOntologyCellularComponent	actin cytoskeleton	MYH3 DST MYH13 MYO9B SPTA1 FER BIN2 ACTN2	9.41e-05	576	53	8	GO:0015629
GeneOntologyCellularComponent	cell cortex	DST MYO9B SPTA1 FER BIN2 ACTN2	3.41e-04	371	53	6	GO:0005938
GeneOntologyCellularComponent	sarcomere	MYH3 DST SYNE2 ACTN2 GRIN2B	4.15e-04	249	53	5	GO:0030017
GeneOntologyCellularComponent	myosin complex	MYH3 MYH13 MYO9B	4.53e-04	59	53	3	GO:0016459
GeneOntologyCellularComponent	Z disc	DST SYNE2 ACTN2 GRIN2B	5.82e-04	151	53	4	GO:0030018
GeneOntologyCellularComponent	actin-based cell projection	ANGPT1 MYO9B SYNE2 ACTN2 PKHD1L1	6.84e-04	278	53	5	GO:0098858
GeneOntologyCellularComponent	muscle myosin complex	MYH3 MYH13	7.40e-04	16	53	2	GO:0005859
GeneOntologyCellularComponent	I band	DST SYNE2 ACTN2 GRIN2B	8.29e-04	166	53	4	GO:0031674
GeneOntologyCellularComponent	postsynaptic actin cytoskeleton	MYO9B ACTN2	1.05e-03	19	53	2	GO:0098871
GeneOntologyCellularComponent	vesicle lumen	AMPD3 GUSB APOB BIN2 ACTN2	1.51e-03	332	53	5	GO:0031983
GeneOntologyCellularComponent	myosin filament	MYH3 MYH13	1.82e-03	25	53	2	GO:0032982
GeneOntologyCellularComponent	postsynaptic cytoskeleton	MYO9B ACTN2	1.97e-03	26	53	2	GO:0099571
GeneOntologyCellularComponent	myosin II complex	MYH3 MYH13	2.29e-03	28	53	2	GO:0016460
Domain	Spectrin	DST SPTA1 SYNE2 ACTN2	4.55e-07	23	52	4	PF00435
Domain	Spectrin_repeat	DST SPTA1 SYNE2 ACTN2	1.21e-06	29	52	4	IPR002017
Domain	Spectrin/alpha-actinin	DST SPTA1 SYNE2 ACTN2	1.81e-06	32	52	4	IPR018159
Domain	SPEC	DST SPTA1 SYNE2 ACTN2	1.81e-06	32	52	4	SM00150
Domain	Actinin_actin-bd_CS	DST SYNE2 ACTN2	3.47e-05	23	52	3	IPR001589
Domain	ACTININ_2	DST SYNE2 ACTN2	3.47e-05	23	52	3	PS00020
Domain	ACTININ_1	DST SYNE2 ACTN2	3.47e-05	23	52	3	PS00019
Domain	RA	MYO9B RASSF6 RASSF2	8.66e-05	31	52	3	SM00314
Domain	EF-hand_Ca_insen	SPTA1 ACTN2	1.13e-04	6	52	2	IPR014837
Domain	C-RASSF	RASSF6 RASSF2	1.13e-04	6	52	2	IPR033614
Domain	Nore1-SARAH	RASSF6 RASSF2	1.13e-04	6	52	2	PF16517
Domain	EFhand_Ca_insen	SPTA1 ACTN2	1.13e-04	6	52	2	PF08726
Domain	RA	MYO9B RASSF6 RASSF2	1.36e-04	36	52	3	PF00788
Domain	RA	MYO9B RASSF6 RASSF2	1.48e-04	37	52	3	PS50200
Domain	Myosin_head_motor_dom	MYH3 MYH13 MYO9B	1.60e-04	38	52	3	IPR001609
Domain	MYOSIN_MOTOR	MYH3 MYH13 MYO9B	1.60e-04	38	52	3	PS51456
Domain	Myosin_head	MYH3 MYH13 MYO9B	1.60e-04	38	52	3	PF00063
Domain	MYSc	MYH3 MYH13 MYO9B	1.60e-04	38	52	3	SM00242
Domain	RA_dom	MYO9B RASSF6 RASSF2	1.87e-04	40	52	3	IPR000159
Domain	SARAH	RASSF6 RASSF2	2.70e-04	9	52	2	PS50951
Domain	SARAH_dom	RASSF6 RASSF2	2.70e-04	9	52	2	IPR011524
Domain	TPR_2	TMTC1 BBS4 IFIT3	3.64e-04	50	52	3	PF07719
Domain	TPR_2	TMTC1 BBS4 IFIT3	3.64e-04	50	52	3	IPR013105
Domain	TPR_8	TMTC1 BBS4 IFIT3	4.32e-04	53	52	3	PF13181
Domain	Myosin_N	MYH3 MYH13	7.80e-04	15	52	2	PF02736
Domain	Myosin_N	MYH3 MYH13	7.80e-04	15	52	2	IPR004009
Domain	CH	DST SYNE2 ACTN2	7.87e-04	65	52	3	SM00033
Domain	CH	DST SYNE2 ACTN2	9.77e-04	70	52	3	PF00307
Domain	IQ	MYH3 MYH13 MYO9B	1.02e-03	71	52	3	PF00612
Domain	-	DST SYNE2 ACTN2	1.02e-03	71	52	3	1.10.418.10
Domain	CH	DST SYNE2 ACTN2	1.10e-03	73	52	3	PS50021
Domain	Myosin_tail_1	MYH3 MYH13	1.13e-03	18	52	2	PF01576
Domain	Myosin_tail	MYH3 MYH13	1.13e-03	18	52	2	IPR002928
Domain	CH-domain	DST SYNE2 ACTN2	1.19e-03	75	52	3	IPR001715
Domain	Myosin-like_IQ_dom	MYH3 MYH13	1.26e-03	19	52	2	IPR027401
Domain	-	MYH3 MYH13	1.26e-03	19	52	2	4.10.270.10
Domain	IQ	MYH3 MYH13 MYO9B	1.49e-03	81	52	3	SM00015
Domain	TPR_1	TMTC1 BBS4 IFIT3	2.02e-03	90	52	3	PF00515
Domain	TPR_1	TMTC1 BBS4 IFIT3	2.02e-03	90	52	3	IPR001440
Domain	IQ_motif_EF-hand-BS	MYH3 MYH13 MYO9B	2.02e-03	90	52	3	IPR000048
Domain	IQ	MYH3 MYH13 MYO9B	2.21e-03	93	52	3	PS50096
Domain	IPT	EBF2 PKHD1L1	2.55e-03	27	52	2	SM00429
Domain	TIG	EBF2 PKHD1L1	3.36e-03	31	52	2	PF01833
Domain	IPT	EBF2 PKHD1L1	3.57e-03	32	52	2	IPR002909
Domain	EF_HAND_2	DST SPTA1 ACTN2 PPP2R3C	3.88e-03	231	52	4	PS50222
Domain	EF_hand_dom	DST SPTA1 ACTN2 PPP2R3C	3.94e-03	232	52	4	IPR002048
Domain	TPR	TMTC1 BBS4 IFIT3	5.56e-03	129	52	3	SM00028
Pubmed	Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.	AMPD3 TMTC1 RASSF6 DDX60 EXD2 VPS50 RXFP1 SCLT1 PKHD1L1	1.03e-06	686	54	9	29987050
Pubmed	Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma.	RASSF6 RASSF2	2.37e-06	2	54	2	26456015
Pubmed	BPAG1 isoform-b: complex distribution pattern in striated and heart muscle and association with plectin and alpha-actinin.	DST ACTN2	7.09e-06	3	54	2	19932097
Pubmed	Substrate-selective and calcium-independent activation of CaMKII by α-actinin.	ACTN2 GRIN2B	7.09e-06	3	54	2	22427672
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	EPRS1 MYH3 ERCC5 DST MYH13 SPTA1 SYNE2 TENM1 ANKRD30A APOB ACTN2	1.11e-05	1442	54	11	35575683
Pubmed	Competitive binding of alpha-actinin and calmodulin to the NMDA receptor.	ACTN2 GRIN2B	2.36e-05	5	54	2	9009191
Pubmed	Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2.	ACTN2 GRIN2B	3.54e-05	6	54	2	16120608
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH3 MYH13	3.54e-05	6	54	2	10077619
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH3 MYH13	4.94e-05	7	54	2	35210422
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	MYH3 ERCC5 DST MYH13 RASSF6 RASSF2 FER SIN3A	7.64e-05	910	54	8	36736316
Pubmed	NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity.	ACTN2 GRIN2B	8.46e-05	9	54	2	16710293
Pubmed	Frequent epigenetic inactivation of RASSF2 in thyroid cancer and functional consequences.	RASSF6 RASSF2	8.46e-05	9	54	2	20920251
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	SOX6 MYH3 ACTN2	1.03e-04	58	54	3	21884692
Pubmed	An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles.	MYH3 ACTN2	1.29e-04	11	54	2	11988168
Pubmed	A genome-wide association study of aging.	BIN2 GRIN2B	1.29e-04	11	54	2	21782286
Pubmed	Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma.	ACTN2 GRIN2B	1.55e-04	12	54	2	8615909
Pubmed	Developmental rearrangements of cortical glutamate-NMDA receptor binding sites in late human gestation.	ACTN2 GRIN2B	1.55e-04	12	54	2	8665664
Pubmed	Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle.	ACTN2 GRIN2B	1.55e-04	12	54	2	12815021
Pubmed	Mapping genes that control hormone-induced ovulation rate in mice.	GUSB SPTA1	2.13e-04	14	54	2	10491617
Pubmed	Ras-specific exchange factor GRF: oligomerization through its Dbl homology domain and calcium-dependent activation of Raf.	ACTN2 GRIN2B	2.13e-04	14	54	2	10373510
Pubmed	Linkage mapping of 40 randomly isolated liver cDNA clones in the mouse.	GUSB SPTA1 APOB	2.30e-04	76	54	3	8288233
Pubmed	C2cd3 is critical for centriolar distal appendage assembly and ciliary vesicle docking in mammals.	BBS4 SCLT1	2.45e-04	15	54	2	24469809
Pubmed	The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1.	ACTN2 GRIN2B	2.45e-04	15	54	2	14622581
Pubmed	Adjacent asparagines in the NR2-subunit of the NMDA receptor channel control the voltage-dependent block by extracellular Mg2+.	ACTN2 GRIN2B	2.45e-04	15	54	2	9481670
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	EPRS1 MYO9B DDX60 ANKRD30A	2.78e-04	202	54	4	33005030
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	SOX6 MYH3	3.17e-04	17	54	2	16124007
Pubmed	Proteomic analysis of NMDA receptor-adhesion protein signaling complexes.	SPTA1 ACTN2 GRIN2B	3.31e-04	86	54	3	10862698
Pubmed	A physical interaction network of dengue virus and human proteins.	DST APOB	3.56e-04	18	54	2	21911577
Pubmed	Non conservation of function for the evolutionarily conserved prdm1 protein in the control of the slow twitch myogenic program in the mouse embryo.	SOX6 MYH3	3.56e-04	18	54	2	22522309
Pubmed	Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1.	MYH3 ACTN2	3.56e-04	18	54	2	26688546
Pubmed	Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.	COL4A4 TENM1 GRIN2B	3.90e-04	91	54	3	22610502
Pubmed	Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.	SIAE GUSB	3.98e-04	19	54	2	29514215
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	DST SYNE2 SCLT1	4.03e-04	92	54	3	15840729
Pubmed	QKI is a critical pre-mRNA alternative splicing regulator of cardiac myofibrillogenesis and contractile function.	DST ACTN2	4.42e-04	20	54	2	33397958
Pubmed	Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome.	ACTN2 GRIN2B	4.42e-04	20	54	2	16635246
Pubmed	Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome.	MYH3 ACTN2	4.42e-04	20	54	2	7588068
Pubmed	Chromosomal localization of seven members of the murine TGF-beta superfamily suggests close linkage to several morphogenetic mutant loci.	GUSB SPTA1	4.88e-04	21	54	2	1970330
Pubmed	Common variants in left/right asymmetry genes and pathways are associated with relative hand skill.	MYH3 CHSY1	6.94e-04	25	54	2	24068947
Pubmed	Deletion of the T-box transcription factor gene, Tbx1, in mice induces differential expression of genes associated with cleft palate in humans.	MYH3 ACTN2	7.51e-04	26	54	2	30121012
Pubmed	Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.	MYH3 EPG5	8.10e-04	27	54	2	18649358
Pubmed	Bardet-Biedl Syndrome Overview	BBS4 SCLT1	8.10e-04	27	54	2	20301537
Pubmed	Genetic regulation of cholesterol homeostasis: chromosomal organization of candidate genes.	GUSB SPTA1 APOB	8.95e-04	121	54	3	8827514
Pubmed	Identification and characterization of SAP25, a novel component of the mSin3 corepressor complex.	SIN3A IFIT3	1.00e-03	30	54	2	16449650
Pubmed	Integrin linked kinase (ILK) is required for lens epithelial cell survival, proliferation and differentiation.	DST ACTN2	1.00e-03	30	54	2	24472646
Pubmed	Vti1b promotes TRPV1 sensitization during inflammatory pain.	EPRS1 DST ACTN2	1.03e-03	127	54	3	30335684
Pubmed	Absence of canonical Smad signaling in ureteral and bladder mesenchyme causes ureteropelvic junction obstruction.	MYH3 ACTN2	1.07e-03	31	54	2	22282597
Pubmed	D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function.	COL4A4 ANGPT1	1.07e-03	31	54	2	22925884
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	MON2 DST EXD2 SYNE2 TENM1	1.10e-03	504	54	5	34432599
Pubmed	Lem2 is essential for cardiac development by maintaining nuclear integrity.	SYNE2 ACTN2	1.14e-03	32	54	2	37067297
Pubmed	Dgcr8 functions in the secondary heart field for outflow tract and right ventricle development in mammals.	SOX6 ANGPT1	1.14e-03	32	54	2	38110169
Pubmed	HOXA5 Participates in Brown Adipose Tissue and Epaxial Skeletal Muscle Patterning and in Brown Adipocyte Differentiation.	EBF2 MYH3	1.14e-03	32	54	2	33732701
Pubmed	Tandem immunoprecipitation of phosphotyrosine-mass spectrometry (TIPY-MS) indicates C19ORF19 becomes tyrosine-phosphorylated and associated with activated epidermal growth factor receptor.	DDX60 FER	1.21e-03	33	54	2	18271526
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	DST MYH13 EXD2 APOB SCLT1 PKHD1L1	1.27e-03	777	54	6	35844135
Pubmed	alphaII-Spectrin interacts with five groups of functionally important proteins in the nucleus.	ERCC5 SPTA1	1.29e-03	34	54	2	16889989
Pubmed	Hypertrophic Cardiomyopathy Overview	CALR3 ACTN2	1.29e-03	34	54	2	20301725
Interaction	STK3 interactions	MYH3 DST MYH13 RASSF6 RASSF2 BIN2	6.22e-06	181	51	6	int:STK3
Cytoband	Ensembl 112 genes in cytogenetic band chr4q32	DDX60 RXFP1 TDO2	3.92e-04	120	54	3	chr4q32
Cytoband	Ensembl 112 genes in cytogenetic band chr8q23	ANGPT1 PKHD1L1	1.67e-03	51	54	2	chr8q23
GeneFamily	Ras association domain family	RASSF6 RASSF2	1.72e-04	10	36	2	1198
GeneFamily	Myosin heavy chains	MYH3 MYH13	3.98e-04	15	36	2	1098
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	TMTC1 BBS4 IFIT3	1.54e-03	115	36	3	769
Coexpression	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	ANGPT1 DDX60 SPTA1 RXFP1 IFIT3	1.75e-05	156	54	5	M17275
Coexpression	MOSERLE_IFNA_RESPONSE	DDX60 RTP4 IFIT3	3.57e-05	31	54	3	M3218
Coexpression	GSE13229_IMM_VS_MATURE_NKCELL_UP	EBF2 SOX6 CRTAM ASPHD2 RTP4	5.74e-05	200	54	5	M3205
Coexpression	GSE34006_WT_VS_A2AR_KO_TREG_DN	DDX60 SYNE2 VPS50 RTP4 IFIT3	5.74e-05	200	54	5	M9042
Coexpression	GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP	TENM1 TDO2 PKHD1L1 RTP4 IFIT3	5.74e-05	200	54	5	M7322
Coexpression	MATZUK_SPERMATOZOA	BRDT BBS4 APOB RXFP1	9.08e-05	114	54	4	M1833
Coexpression	LAIHO_COLORECTAL_CANCER_SERRATED_UP	MON2 EPRS1 RASSF2 DDX60	9.39e-05	115	54	4	M16586
Coexpression	MATZUK_SPERMATOZOA	BRDT BBS4 APOB RXFP1	9.71e-05	116	54	4	MM1236
CoexpressionAtlas	kidney_adult_RenalCapsule_k-means-cluster#4_top-relative-expression-ranked_500	TMTC1 DDX60 RTP4 IFIT3	1.82e-05	64	52	4	gudmap_kidney_adult_RenalCapsule_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#2_top-relative-expression-ranked_500	EBF2 SOX6 MYH3 SPTA1 APOB ACTN2	2.96e-05	246	52	6	gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k2
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN4\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DDX60 CRTAM ACTN2 RTP4 IFIT3	2.09e-06	172	54	5	d098e8a9c7666354803225cf2650faad436bab66
ToppCell	BAL-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	SIAE ZNF283 BBS4 SCLT1 GPA33	2.69e-06	181	54	5	f370161afef2ec827a7b194c06abb9ac1a507cbb
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 TENM1 APOB GRIN2B PKHD1L1	2.91e-06	184	54	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 TENM1 APOB GRIN2B PKHD1L1	2.91e-06	184	54	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPTA1 TENM1 APOB GRIN2B PKHD1L1	2.91e-06	184	54	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Control-Myeloid-ncMonocyte\|Control / Disease state, Lineage and Cell class	TMTC1 MYO9B RASSF2 CHSY1 SCLT1	3.87e-06	195	54	5	fcb05948e7480dc53f06f3fc9b9c3fc129874edd
ToppCell	Bronchus_Control_(B.)-Immune-TX-TRAM-1\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	COL4A4 ERCC5 BRDT IFIT3 GPA33	3.87e-06	195	54	5	dabf667875ed48fdce4f803f5ead39c71a6df42b
ToppCell	Control-Myeloid-ncMonocyte\|World / Disease state, Lineage and Cell class	TMTC1 MYO9B RASSF2 CHSY1 SCLT1	3.87e-06	195	54	5	b4444b67a709e82b8e2ee510924c3152cb88b051
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-dn_T\|COVID-19_Severe / Disease, condition lineage and cell class	SYNE2 CRTAM TENM1 RTP4 GPA33	4.37e-06	200	54	5	d01aa5fccada22f97d8350ad5888df2aadb5bb1c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 CRTAM RTP4 IFIT3	1.83e-05	129	54	4	f83187c0bb06528127b8d2d56674ab1946846951
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Mme_Fam114a1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 APOB RTP4 IFIT3	2.06e-05	133	54	4	fc319644868078ea0f88a71d55f5e858c6848b50
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	DST ASPHD2 GREB1 GRIN2B	2.38e-05	138	54	4	8d70e64843f7c3be8ee4203cc126fdf1001f0df5
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 LRATD1 RTP4 IFIT3	3.75e-05	155	54	4	5c7b68b59244525e3714806c205a57a2daebf423
ToppCell	facs-Spleen-nan-18m-Lymphocytic-NK_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMTC1 ANGPT1 CRTAM CHSY1	3.94e-05	157	54	4	a84377028c661f8f3ecae0f6082abdd859faf0c8
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 MYH13 RTP4 IFIT3	4.35e-05	161	54	4	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYH3 DDX60 ZNF283 CUZD1	4.45e-05	162	54	4	6ffcf369d954c20ce036aa1d072cee4e205f728e
ToppCell	PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYH3 DDX60 ZNF283 CUZD1	4.45e-05	162	54	4	bcbf7f80a2a1c80def795e345f16cf16e8b9d03b
ToppCell	Endothelial-B-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	TMTC1 LRATD1 GRIN2B PKHD1L1	4.78e-05	165	54	4	b6893882472aeb0d18e26f47eaec9d53688afcde
ToppCell	Endothelial-B-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	TMTC1 LRATD1 GRIN2B PKHD1L1	5.13e-05	168	54	4	4977c3837fbb1f36c89fddd5764e37290ac25ad8
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 MYH13 RTP4 IFIT3	5.37e-05	170	54	4	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRTAM ACTN2 RTP4 IFIT3	5.88e-05	174	54	4	319bfafc66a21ad05ab35e0fd024c8b372a07165
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SYNE2 LRATD1 TDO2 PKHD1L1	5.88e-05	174	54	4	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	RSV-Healthy-1\|Healthy / Virus stimulation, Condition and Cluster	MYO9B DDX60 RTP4 IFIT3	6.01e-05	175	54	4	ff3a27f512a3a710ebc863b7b75cce8167d5440b
ToppCell	RSV-Healthy-1\|RSV / Virus stimulation, Condition and Cluster	MYO9B DDX60 RTP4 IFIT3	6.01e-05	175	54	4	ca52b99b03535a5b3a2751d6981708dc5b255b91
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A4 LRATD1 TDO2 PKHD1L1	6.42e-05	178	54	4	a107dd98a07086ed0429116095ecda60c9dbef1e
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231\|Adult / Lineage, Cell type, age group and donor	TMTC1 LRATD1 GRIN2B PKHD1L1	6.42e-05	178	54	4	c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDX60 ICE2 SYNE2 IFIT3	7.00e-05	182	54	4	1aea96ee211f7b9caef7fd385233f51be6021a73
ToppCell	COVID-19_Mild-CD4+_T_activated\|COVID-19_Mild / Disease condition and Cell class	DST DDX60 ICE2 IFIT3	7.00e-05	182	54	4	877b6e611626628e709568747512f2827ebb2795
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DDX60 ICE2 SYNE2 IFIT3	7.00e-05	182	54	4	b427e43ee523a3ea9eca3207f3d82042f10f022a
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 ICE2 SYNE2 IFIT3	7.00e-05	182	54	4	c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5
ToppCell	E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL4A4 LRATD1 TDO2 PKHD1L1	7.00e-05	182	54	4	9966f42c338cbd471efa8ffc765a6ce93693aa75
ToppCell	PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 ICE2 SYNE2 IFIT3	7.00e-05	182	54	4	4cb182ef39be2044a6ad7266f332d4177591e550
ToppCell	COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated\|COVID-19_Mild / Disease group, lineage and cell class	DDX60 ICE2 SYNE2 IFIT3	7.15e-05	183	54	4	7717fce227b4e02ed41baad8ae7dd2e22bd7c13e
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	DST DDX60 SYNE2 IFIT3	7.15e-05	183	54	4	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	Control-Endothelial_cells-Pulmonary_venous_endothelial_cells\|Control / group, cell type (main and fine annotations)	TMTC1 CHSY1 RXFP1 PKHD1L1	7.15e-05	183	54	4	46be9f96755c7b65aeac061d95d15abeb6466034
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 TMTC1 ANGPT1 RXFP1	7.30e-05	184	54	4	c5436a8e45f471b8d1301abbe9c7879204537f52
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	7.30e-05	184	54	4	7f6c8912677764d438ab0555faca344d74c2f483
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 TMTC1 ANGPT1 RXFP1	7.45e-05	185	54	4	7092436b4db90289516ed130ade596e3021cffaf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	EBF2 TMTC1 ANGPT1 RXFP1	7.45e-05	185	54	4	a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	7.61e-05	186	54	4	948815663c212c4311329d503b5991cbbbff9808
ToppCell	COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated\|COVID-19_Severe / Disease group, lineage and cell class	DDX60 SYNE2 CRTAM IFIT3	7.77e-05	187	54	4	4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX6 SPTA1 APOB TDO2	7.77e-05	187	54	4	edb0ab0154542b1c0b3a2c216c4a60f0f06290b3
ToppCell	T_cells-ISG-high_CD4+_T_cells\|World / Immune cells in Kidney/Urine in Lupus Nephritis	DDX60 SYNE2 RTP4 IFIT3	7.93e-05	188	54	4	6f8946d4710f6e32c937213f99b790b098b8819c
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EBF2 SOX6 COL4A4 MYH13	7.93e-05	188	54	4	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	Endothelial-B\|World / lung cells shred on cell class, cell subclass, sample id	TMTC1 LRATD1 GRIN2B PKHD1L1	7.93e-05	188	54	4	5959a88728812a5f4cbfa54eddc7a73ccbaa2f68
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMTC1 LRATD1 GRIN2B PKHD1L1	7.93e-05	188	54	4	c2805232618a7b6f844d34e37ad458a9923dbfe1
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMTC1 LRATD1 GRIN2B PKHD1L1	7.93e-05	188	54	4	aeecbc057dc823f8fcea8a98f18d213bacc7f4db
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 TMTC1 ANGPT1 RXFP1	8.10e-05	189	54	4	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 TMTC1 ANGPT1 RXFP1	8.10e-05	189	54	4	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	IPF-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	TMTC1 RASSF2 CHSY1 SCLT1	8.10e-05	189	54	4	5c22d2d935f7bb270260b8bc6be67b565ec401bf
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	8.10e-05	189	54	4	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX6 SPTA1 APOB TDO2	8.10e-05	189	54	4	7899af78b273d9c7f029d52f7e0cf6df4da41f5e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	DDX60 SYNE2 CRTAM IFIT3	8.26e-05	190	54	4	b9182c84e44aa31684b5388cf3ef4fd1b9e51de4
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	8.26e-05	190	54	4	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 SYNE2 CRTAM IFIT3	8.26e-05	190	54	4	88c092a5e78ccaddf406f8fff74376bb761b9790
ToppCell	COPD-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	TMTC1 RASSF2 CHSY1 SCLT1	8.26e-05	190	54	4	ed978cd5d9da87b49878a330e362762c487f849f
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDX60 SYNE2 CRTAM IFIT3	8.26e-05	190	54	4	4b42a16902d7d1494f953cc88af1e761e76bdf2c
ToppCell	10x_3'_v3-tissue-resident_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SOX6 SPTA1 APOB TDO2	8.26e-05	190	54	4	a34293601aefe5fb5c400c14091294b9ddaa195b
ToppCell	Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMTC1 LRATD1 GRIN2B PKHD1L1	8.26e-05	190	54	4	6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7
ToppCell	Adult-Endothelial-endothelial_cell_of_lymph_vessel\|Adult / Lineage, Cell type, age group and donor	TMTC1 LRATD1 GRIN2B PKHD1L1	8.26e-05	190	54	4	91bf3b7e9148589757436a53a4f58e0ebfe54400
ToppCell	PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDX60 SYNE2 CRTAM IFIT3	8.26e-05	190	54	4	9501f0995f3d52be90c02b1aa0c7d184bd788c16
ToppCell	Calu_3-infected-SARSCoV2\|infected / Cell line, Condition and Strain	DDX60 SYNE2 RTP4 IFIT3	8.43e-05	191	54	4	2da876d26f37a00dbdf1ee79d724306e8b20f304
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 TMTC1 ANGPT1 RXFP1	8.43e-05	191	54	4	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A4 TMTC1 ANGPT1 RXFP1	8.43e-05	191	54	4	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	IPF-Endothelial-Lymphatic\|IPF / Disease state, Lineage and Cell class	TMTC1 LRATD1 GRIN2B PKHD1L1	8.60e-05	192	54	4	2496edd8f3a41146d418879de9ee2ccc7857431f
ToppCell	IPF-Myeloid-ncMonocyte\|IPF / Disease state, Lineage and Cell class	TMTC1 RASSF2 CHSY1 SCLT1	8.60e-05	192	54	4	e9fb8c57d8094f70fb492909b2bec40aa5f2e5b8
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	EBF2 COL4A4 TMTC1 MYH13	8.60e-05	192	54	4	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	BAL-Mild\|BAL / Compartment, Disease Groups and Clusters	DDX60 RXFP1 RTP4 IFIT3	8.60e-05	192	54	4	1a6cbf014d3f7a3fb6f53adab078c4742e7137de
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	8.78e-05	193	54	4	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	COVID-19_Severe-CD8+_T_activated\|World / disease group, cell group and cell class	DDX60 SYNE2 CRTAM IFIT3	8.78e-05	193	54	4	ddc1db516568e03be8e82b2ca770c67756418185
ToppCell	COPD-Myeloid-ncMonocyte\|COPD / Disease state, Lineage and Cell class	TMTC1 RASSF2 CHSY1 SCLT1	8.78e-05	193	54	4	936ca95995599356b794fba32bfd82d8de339365
ToppCell	Control-Myeloid-ncMonocyte\|Myeloid / Disease state, Lineage and Cell class	TMTC1 RASSF2 CHSY1 SCLT1	8.78e-05	193	54	4	3479c01aaae7afd7e02d00e0cb21951c0106a0fd
ToppCell	RV-10._Endothelium_II\|World / Chamber and Cluster_Paper	TMTC1 SYNE2 CHSY1 PKHD1L1	8.78e-05	193	54	4	2531266bc57339d4e2b22a88817008e32b8c1598
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMTC1 LRATD1 GRIN2B PKHD1L1	8.95e-05	194	54	4	f772a9f9ef8635aeaeb8b022dbb94e9672b36ead
ToppCell	nucseq-Immune-Immune_Myeloid-pMON-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO9B RASSF2 BIN2 SCLT1	8.95e-05	194	54	4	e237384b02be460d44eeada3026a5691c66f6fc1
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	EBF2 COL4A4 CHSY1 SCLT1	8.95e-05	194	54	4	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMTC1 LRATD1 GRIN2B PKHD1L1	8.95e-05	194	54	4	3b73f2d305a7566f7ab567e5f18c82cd3d80e32c
ToppCell	nucseq-Immune-Immune_Myeloid-pMON\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO9B RASSF2 BIN2 SCLT1	8.95e-05	194	54	4	0bc83ae79873a5e473e6e1e3111924cd003986a1
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 DST RXFP1 IFIT3	8.95e-05	194	54	4	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMTC1 TENM1 GREB1	8.95e-05	194	54	4	e5990880961d2469759ce4b3b20ae93ace3ebd1f
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TMTC1 DST RXFP1 IFIT3	8.95e-05	194	54	4	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	nucseq-Endothelial-Endothelial_Lymphatic\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TMTC1 LRATD1 GRIN2B PKHD1L1	8.95e-05	194	54	4	5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48
ToppCell	Children_(3_yrs)-Endothelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TMTC1 LRATD1 RXFP1 PKHD1L1	9.13e-05	195	54	4	094cf6591daa5ffad36e44122b6f524a3a34c2fd
ToppCell	C_05\|World / shred on cell type and cluster	DST DDX60 IFIT3 GPA33	9.32e-05	196	54	4	bf4dfb460a153dbafb2b9b12b360c8757cec22cd
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SYNE2 CRTAM TENM1 BIN2	9.32e-05	196	54	4	17f17edadafdad9f24e88d708d7e1c765503131c
ToppCell	Endothelial\|World / Lineage, Cell type, age group and donor	TMTC1 LRATD1 RXFP1 PKHD1L1	9.32e-05	196	54	4	96c6d78482a130ce4e29f6629972a06d10d7530e
ToppCell	COVID-19_Moderate-CD8+_T_activated\|COVID-19_Moderate / disease group, cell group and cell class	DDX60 SYNE2 BIN2 IFIT3	9.50e-05	197	54	4	4711ecb157e907758a5021248ae8b043d17672c6
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SOX6 DDX60 SYNE2 IFIT3	9.69e-05	198	54	4	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	CV-Mild-1\|CV / Virus stimulation, Condition and Cluster	DDX60 SYNE2 RTP4 IFIT3	9.69e-05	198	54	4	4b078714c49e7befb7b113d72485e712236d35fa
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	DDX60 SYNE2 RTP4 IFIT3	9.88e-05	199	54	4	d3f36ede2fade550ec8f21a0448e71e1ff579ee2
ToppCell	tumor_Lung-Endothelial_cells-Tip-like_ECs\|Endothelial_cells / Location, Cell class and cell subclass	RASSF2 RXFP1 RTP4 IFIT3	9.88e-05	199	54	4	80c8641cfd84436eadf2234f1313749e2f73331f
ToppCell	VE-CD4-antiviral_CD4\|VE / Condition, Cell_class and T cell subcluster	DDX60 SYNE2 RTP4 IFIT3	9.88e-05	199	54	4	056a0538ca5e825ae6195b4c76c208708a014533
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T\|COVID-19_Mild / Disease, condition lineage and cell class	DDX60 SYNE2 TENM1 IFIT3	9.88e-05	199	54	4	f307d4887b28cf60a591439e278fd668409cb104
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	DST ANGPT1 TDO2 ACTN2	1.01e-04	200	54	4	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO9B RASSF2 BIN2 SCLT1	1.01e-04	200	54	4	fd72fe6565e2f4885481991492d58c323ab1ad40
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DST RASSF6 SYNE2 LRATD1	1.01e-04	200	54	4	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated\|COVID-19_Severe / Disease, condition lineage and cell class	DDX60 SYNE2 CRTAM IFIT3	1.01e-04	200	54	4	b7f80b2db07119069fbf3d245cf1ad79e8648bab
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	DST DDX60 SYNE2 IFIT3	1.01e-04	200	54	4	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SOX6 TMTC1 DST SYNE2	1.01e-04	200	54	4	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	DST ANGPT1 TDO2 ACTN2	1.01e-04	200	54	4	bd8cf33502adea320e91ca2af14e1911d88ad374
Drug	Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A	MON2 AMPD3 DDX60 GPR75 VPS50 FER	6.55e-06	198	53	6	2724_DN
Drug	Wang resin	DST SPTA1	1.59e-05	3	53	2	CID000070043
Drug	pU-2	SYNE2 APOB GRIN2B	2.64e-05	25	53	3	CID000448973
Drug	oxindolylalanine	APOB TDO2	3.18e-05	4	53	2	CID000159768
Drug	lithocholate-3-O-glucuronide	GUSB APOB	3.18e-05	4	53	2	CID000126511
Drug	AC1L1AUZ	EPRS1 ERCC5 GUSB APOB TDO2	3.21e-05	157	53	5	CID000001160
Disease	amenorrhea, response to antineoplastic agent	TMTC1 VPS50 APOB	2.45e-06	15	53	3	EFO_0010269, GO_0097327
Disease	myopathy (implicated_via_orthology)	COL4A4 MYH3 MYH13	8.94e-05	48	53	3	DOID:423 (implicated_via_orthology)
Disease	Influenza	DDX60 RTP4 IFIT3	1.14e-04	52	53	3	C0021400
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0110454 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0111269 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0080719 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0111602 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0080326 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH3 MYH13	1.41e-04	10	53	2	DOID:0111596 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH3 MYH13	2.07e-04	12	53	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH3 MYH13	2.07e-04	12	53	2	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH3 MYH13	2.44e-04	13	53	2	DOID:397 (implicated_via_orthology)
Disease	serum metabolite measurement	EBF2 SOX6 COL4A4 SIAE ANGPT1 SYNE2 FER APOB	2.65e-04	945	53	8	EFO_0005653
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	RASSF6 APOB	2.84e-04	14	53	2	EFO_0004611, EFO_0008589
Disease	distal arthrogryposis (implicated_via_orthology)	MYH3 MYH13	3.27e-04	15	53	2	DOID:0050646 (implicated_via_orthology)
Disease	testosterone measurement	EBF2 SOX6 AMPD3 MYO9B ICE2 SYNE2 CRTAM SIN3A GREB1	4.07e-04	1275	53	9	EFO_0004908
Disease	urinary microalbumin measurement	MON2 COL4A4	5.89e-04	20	53	2	EFO_0010967
Disease	obsolete aging	COL4A4 TMTC1 GRIN2B ZNF248	1.59e-03	279	53	4	GO_0007568
Disease	response to vaccine, cytokine measurement	COL4A4 TENM1 GRIN2B	1.70e-03	131	53	3	EFO_0004645, EFO_0004873

Protein segments in the cluster

Peptide	Gene	Start	Entry
QKLLYQQHKNALGYH	EPG5	1186	Q9HCE0
LNYAVLLYNQGEKKN	BBS4	376	Q96RK4
LLYNQGEKKNALAQY	BBS4	381	Q96RK4
NQLKQYEHNIINYKN	ACTN2	676	P35609
YEHNIINYKNNIDKL	ACTN2	681	P35609
DIDQKNLNGKSQYYI	CALR3	116	Q96L12
VNALGLHNYYDVVKN	BRDT	301	Q58F21
YNNHLKNRIYQYEKE	ANKRD30A	1376	Q9BXX3
YSLLYLEGQEKAHNQ	COL4A4	1491	P53420
EKTNNGTHYKLQLLY	EBF2	101	Q9HAK2
NEKQNYRLYLKGHTG	ANGPT1	396	Q15389
YQQQAEGHKLYKDLK	BIN2	51	Q9UBW5
LSHQEKQKFLGQNYY	AMPD3	706	Q01432
HLKTYNLYYEGQNLQ	RASSF2	26	P50749
LKTYNIFYENQKNLH	RASSF6	61	Q6ZTQ3
LRVYGQYLNLDKDHN	PPP2R3C	276	Q969Q6
NKNYIHGELYKNRVS	GPA33	76	Q99795
QKHLKYYLVRNAQGT	GREB1	186	Q4ZG55
GNNLKDLVDKYQHYE	DST	4036	Q03001
FYYENENVKGLHLNL	DDX60	386	Q8IY21
SNYYDNHLKQQLAKE	EXD2	466	Q9NVH0
QQYYLKVHLGENKVH	LRATD1	241	Q96KN4
QYGQLETKHIANAKY	MON2	1376	Q7Z3U7
NYNKLQHVQTRGYTK	GPR75	276	O95800
NLKGAYQNNEIKHIY	APOB	1826	P04114
GLNQKLYHNLQEYAK	ASPHD2	121	Q6ICH7
NSKAVGINKNDYLQY	ICE2	121	Q659A1
NEYPALKNSKYQLLH	CRTAM	61	O95727
VLALKGAQLHQNQYY	FER	186	P16591
YQKSLLEQYHLGLDQ	GUSB	561	P08236
EKQQSHQRYCNLQKY	IFIT3	356	O14879
HQRYCNLQKYNGKSE	IFIT3	361	O14879
NSKRYQALGHLLEQY	FAM172BP	51	A6NC97
HFVNQRADYKYQKLQ	CUZD1	591	Q86UP6
SNLVQHILKKYYGNG	RTP4	116	Q96DX8
KAALLNQHYQVNFKG	EPRS1	216	P07814
YKNLAGECQNINKQY	SYNE2	546	Q8WXH0
IYGNYLHLEKVLNAQ	TDO2	41	P48775
LNSDQYQYMNGKNKH	SAMD8	126	Q96LT4
QYQLKGLLKKNYLNQ	ERCC5	231	P28715
KNYQVLLGNIQLYHQ	PRSS47P	131	A8MTI9
NEKYYLKSLDHQGIN	SIN3A	721	Q96ST3
AHKGLLNLTYYQQIQ	SIAE	416	Q9HAT2
FEYNSNGLLQKAYNK	TENM1	2226	Q9UKZ4
NKLYDQHLGKSNNFQ	MYH3	551	P11055
YNHKQIEQLYAAQLA	SOX6	361	P35712
YEQNKKGYIRDLHNS	CHSY1	281	Q86X52
NHYTKVQQAYRLLGK	VPS50	251	Q96JG6
HYNYANFLKDQGRNK	TMTC1	486	Q8IUR5
KNKLYDQHLGKSNNF	MYH13	551	Q9UKX3
FKNYHDLQKLYLQNN	RXFP1	146	Q9HBX9
HLGELNGQLKYYQKQ	SCLT1	66	Q96NL6
YEDPTNIQGKYQKHQ	SPTA1	81	P02549
NYIGLKFQYQDNSKI	PKHD1L1	756	Q86WI1
KYDQKRNAINYHQDL	ZNF248	191	Q8NDW4
GKNYLSAYQLNVHQR	ZNF283	241	Q8N7M2
KQPEDYFYLNQHNLK	MYO9B	356	Q13459
GNLQLKDSNVYQDHY	GRIN2B	971	Q13224